Literature DB >> 1928392

Cerebral oxidative metabolism and redox state during hypoxia-ischemia and early recovery in immature rats.

J Y Yager1, R M Brucklacher, R C Vannucci.   

Abstract

Intracellular pH (pHi) and cytoplasmic and mitochondrial oxidation-reduction (redox) states of cerebral tissue were examined in relation to perturbations of glycolytic and tricarboxylic acid cycle intermediates and of high-energy phosphate reserves during hypoxia-ischemia and the early recovery period in the immature rat. Seven-day postnatal rats underwent unilateral common carotid artery ligation and exposure to 8% O2 for 3 h, after which they were quick frozen in liquid N2 at the terminus of hypoxia-ischemia and at 10, 30, 60, and 240 min of recovery for enzymatic fluorometric analysis of cerebral metabolites. During hypoxia-ischemia, concentrations of glucose and alpha-ketoglutarate in the cerebral hemisphere ipsilateral to the carotid artery occlusion were depleted to 10 and 70% of control, respectively; pyruvate was unchanged. During recovery, glucose, pyruvate, and alpha-ketoglutarate increased above their respective control values. Calculated pHi decreased from 7.0 (control) to 6.6 during hypoxia-ischemia and normalized by 10 min of recovery. The cytoplasmic NAD+/NADH ratio decreased (increased reduction) to 50% of control during hypoxia-ischemia and remained in the reduced state throughout 4 h of recovery. Paradoxically, mitochondrial NAD+/NADH was oxidized at the terminus of hypoxia-ischemia. The mitochondrial oxidation which developed during hypoxia-ischemia presumably results from a limitation of cellular substrate (glucose) supply, which in turn leads to a depletion of high-energy phosphate reserves, culminating in brain damage.

Entities:  

Mesh:

Year:  1991        PMID: 1928392     DOI: 10.1152/ajpheart.1991.261.4.H1102

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Extended ischemia prevents HIF1alpha degradation at reoxygenation by impairing prolyl-hydroxylation: role of Krebs cycle metabolites.

Authors:  Anna Serra-Pérez; Anna M Planas; Analía Núñez-O'Mara; Edurne Berra; Judit García-Villoria; Antònia Ribes; Tomàs Santalucía
Journal:  J Biol Chem       Date:  2010-04-05       Impact factor: 5.157

Review 2.  Glucose and Intermediary Metabolism and Astrocyte-Neuron Interactions Following Neonatal Hypoxia-Ischemia in Rat.

Authors:  Eva Brekke; Hester Rijkje Berger; Marius Widerøe; Ursula Sonnewald; Tora Sund Morken
Journal:  Neurochem Res       Date:  2016-12-26       Impact factor: 3.996

3.  Relation between delayed impairment of cerebral energy metabolism and infarction following transient focal hypoxia-ischaemia in the developing brain.

Authors:  R M Blumberg; E B Cady; J S Wigglesworth; J E McKenzie; A D Edwards
Journal:  Exp Brain Res       Date:  1997-01       Impact factor: 1.972

Review 4.  Assessing Cerebral Metabolism in the Immature Rodent: From Extracts to Real-Time Assessments.

Authors:  Alkisti Mikrogeorgiou; Duan Xu; Donna M Ferriero; Susan J Vannucci
Journal:  Dev Neurosci       Date:  2019-04-16       Impact factor: 2.984

5.  Changing metabolic and energy profiles in fetal, neonatal, and adult rat brain.

Authors:  W David Lust; Svetlana Pundik; Jennifer Zechel; Yinong Zhou; Marek Buczek; Warren R Selman
Journal:  Metab Brain Dis       Date:  2003-09       Impact factor: 3.584

Review 6.  Mitochondrial mechanisms of cell death and neuroprotection in pediatric ischemic and traumatic brain injury.

Authors:  Courtney L Robertson; Susanna Scafidi; Mary C McKenna; Gary Fiskum
Journal:  Exp Neurol       Date:  2009-05-07       Impact factor: 5.330

7.  Maintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection.

Authors:  Hua Shen; Krzysztof L Hyrc; Mark P Goldberg
Journal:  Neurobiol Dis       Date:  2013-07-24       Impact factor: 5.996

8.  Evaluation of 2-[¹⁸F]fluoroacetate kinetics in rodent models of cerebral hypoxia-ischemia.

Authors:  Yu Ouyang; Jeff N Tinianow; Simon R Cherry; Jan Marik
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-12       Impact factor: 6.200

9.  The pentose phosphate pathway and pyruvate carboxylation after neonatal hypoxic-ischemic brain injury.

Authors:  Eva M F Brekke; Tora S Morken; Marius Widerøe; Asta K Håberg; Ann-Mari Brubakk; Ursula Sonnewald
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-05       Impact factor: 6.200

10.  Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia.

Authors:  R Chavez-Valdez; L J Martin; D L Flock; F J Northington
Journal:  Neuroscience       Date:  2012-05-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.